Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$3.66 +0.05 (+1.39%)
At close: Oct 20, 2026 · 4:00 PM EDT

Recursion Pharmaceuticals (RXRX) Deferred Taxes (2025 - 2026)

Updated

Recursion Pharmaceuticals (RXRX) reported Deferred Taxes of -$3,000 for Q2 2026, compared with $638,000 a year earlier.

Analysis

Recursion Pharmaceuticals (RXRX) Deferred Taxes (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Recursion Pharmaceuticals' Deferred Taxes came in at -$4.38 million.

  • Five-year quarterly Deferred Taxes spans a low of -$4.6 million in Q1 2026 and a high of $638,000 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -479.00 Mn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -195.00 Mn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -587.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -1.32 Bn
10 Recursion Pharmaceuticals 1.94 Bn -665.13 Mn -3.82 Mn -3,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,000.00
Mar 31, 2026 -4.60 Mn
Jun 30, 2025 638,000.00
Mar 31, 2025 -419,000.00
API Access

Recursion Pharmaceuticals Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=RXRX&period=max&api_key=YOUR_API_KEY